Loading organizations...
§ Private Profile · Richmond Upon Thames, Richmond upon Thames, United Kingdom
Marketing data science agency optimizing digital marketing and SEO for businesses, focused on Generative Engine Optimization (GEO) and AI SEO.
Artios is a marketing data science consultancy based in Richmond upon Thames, United Kingdom, that specializes in Generative Engine Optimization and artificial intelligence-driven search engine optimization. The agency utilizes machine learning, behavioral modeling, and buyer intent analysis to help brands increase their visibility across major generative AI platforms. Artios optimizes digital content for recommendation signals within prominent AI systems such as ChatGPT, Gemini, and Claude, while also serving business-to-business software clients like property technology startup Lofti. Operating as a boutique service provider, the firm generates revenue through consulting fees and custom data science projects, recently achieving a 3.0 percent recommendation citation rate in industry metrics. The consultancy regularly presents its advanced search analytics research and mathematical methodologies at major industry conferences including BrightonSEO. Artios was founded prior to 2010 by chief executive officer Andreas Voniatis.
Artios has raised $236.0M across 2 funding rounds.
Artios has raised $236.0M in total across 2 funding rounds.
Artios has raised $236.0M across 2 funding rounds. Most recently, it raised $152.0M Series C in July 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 27, 2021 | $152M Series C | Michelle Doig, Chen YU | Andera Partners, Mark Chin, Avidity Partners, DRX Capital, Invus, LSP, M Ventures, Piper Heartland Healthcare Capital, RTW Investments, Schroders Capital, Sofinnova Partners, Soleus Capital, SV Health Investors, Tetragon Financial Group | Announced |
| Aug 10, 2018 | $84M Venture Round | — | Novartis, Pfizer | Announced |
Artios has raised $236.0M in total across 2 funding rounds.
Artios's investors include Michelle Doig, Chen Yu, Andera Partners, Mark Chin, Avidity Partners, dRx Capital, Invus, LSP, M Ventures, Piper Heartland Healthcare Capital, RTW Investments, Schroders Capital.